共 239 条
[1]
Deenen JCW(2015)The epidemiology of neuromuscular disorders: a comprehensive overview of the literature J Neuromuscul Dis 2 73-85
[2]
Horlings CGC(2006)Limb-girdle muscular dystrophy in the United States J Neuropathol Exp Neurol 65 995-1003
[3]
Verschuuren JJGM(2018)Genetic landscape and novel disease mechanisms from a largeLGMDcohort of 4656 patients Ann Clin Transl Neurol 5 1574-1587
[4]
Verbeek ALM(2018)Nusinersen versus Sham control in later-onset spinal muscular atrophy N Engl J Med 378 625-635
[5]
van Engelen BGM(2017)Nusinersen versus Sham control in infantile-onset spinal muscular atrophy N Engl J Med 377 1723-1732
[6]
Moore SA(2017)Single-dose gene-replacement therapy for spinal muscular atrophy N Engl J Med 377 1713-1722
[7]
Shilling CJ(2021)Spinal muscular atrophy: from approved therapies to future therapeutic targets for personalized medicine Cell Rep Med 2 100346-968
[8]
Westra S(2023)Recent trends in Antisense therapies for Duchenne muscular dystrophy Pharmaceutics 15 778-297
[9]
Wall C(2023)Delandistrogene moxeparvovec gene therapy in ambulatory patients (aged ≥ 4 to < 8 years) with Duchenne muscular dystrophy: 1-year interim results from Study SRP-9001-103 (ENDEAVOR) Ann Neurol 94 955-869
[10]
Wicklund MP(2009)Limb-girdle muscular dystrophy type 2D gene therapy restores α-sarcoglycan and associated proteins Ann Neurol 66 290-638